Showing results (71-80 of 126) with videos related to
Sort By:
Pageof 13
Metabolism: Clinical and Experimental|September 29, 1998
Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemiaR H Knopp, P Alagona, M Davidson, et al.Circulation|December 1, 1982
Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct sizeC S Liang, H Gavras, J Black, et al.Genetics and Molecular Research : GMR|July 16, 2016
Association between monoamine oxidase B A644G polymorphism and Parkinson's disease risk: a meta-analysis in the Chinese populationJ J Liu, W Wang, M Meng, et al.The American Journal of Physiology|March 11, 1994
Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE contentJ M Delehanty, Y Himura, H Elam, et al.Circulation|March 1, 1988
Comparative effects of nitroprusside and pinacidil on myocardial blood flow and infarct size in awake dogs with acute myocardial infarctionN Imai, C S Liang, C K Stone, et al.European Journal of Pharmacology|August 15, 1996
Elevated myocardial interstitial norepinephrine concentration contributes to the regulation of Na+,K(+)-ATPase in heart failureL P Lai, T H Fan, J M Delehanty, et al.Journal of Clinical Pharmacology|April 1, 1991
Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatmentC K Stone, K L Wellington, A Willick, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failureN Imai, C S Liang, C K Stone, et al.Journal of Molecular and Cellular Cardiology|March 17, 1998
Altered sarcoplasmic reticulum Ca2+ ATPase gene expression in congestive heart failure: effect of chronic norepinephrine infusionL P Lai, V S Raju, J M Delehanty, et al.Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.Pageof 13